For validation, we comparatively assessed the effect of 4-AAQB and cetuximab as single-drug and in combination in KRAS wild-type Caco-2 cells human CRC cell and KRAS-mutant SW1463 human CRC cells (Figure 4). The gene discussed is KRAS; the disease is colorectal carcinoma.